African Journal of Biotechnology

Log in or Register to get access to full text downloads.

Remember me or Register

Molecular dynamic simulation of complex NS2B-NS3 DENV2 protease with potential inhibitors of cyclic tripeptide

Usman Sumo Friend Tambunan, Irwan Kurniawan, Arli Aditya Parikesit


The pathogenic dengue virus (DV) is a growing global threat for which there is no specific treatment and prevention. Several vaccines have been developed against the disease, but they only prevent the disease and reduce the risk of death. Consequently, the antiviral drug becomes the most powerful treatment to solve this problem. The virus possesses a two component NS2B-NS3 protease that cleaves viral precursor proteins, and therefore represents a target for the development of antiviral drugs. In many researches, several models of peptides inhibitor were generated in complexes with the NS2B-NS3 DENV2 protease by performing molecular docking. The goal of this research was to study the interaction of ligands as inhibitors for protein (enzyme) in solvent explicit condition by performing molecular dynamics simulation at 300 and 312 K. The simulations were performed on four disulfide cyclic tripeptide ligands (RGR, KRK, RRA and RKR) and two proline-proline based cyclic peptide ligands (RKK and KKR) compared with linear peptide inhibitor Bz-Nle-K-R-R-H as standard ligand. The results provide conformational changes of enzyme-inhibitor complex that is shown by root-mean-square deviation (RMSD) values. These results show that dynamic behavior of the complex occurs in the presence of solvent. The interaction between ligand and amino acid residue of enzyme changed during simulation. By these parameters, RKR becomes the best ligand compared with others. The ligand has hydrogen bond interaction with the residue of active side, and is stable during simulation at both temperatures. In conclusion, RKR ligand is proposed as an antiviral drug by performing molecular dynamics simulation.

Keywords: Dengue virus, DENV2, NS2B-NS3 protease, inhibitor, cyclic peptide, ligand, molecular dynamics simulation, interaction, conformation, drug.

African Journal of Biotechnology Vol. 12(28), pp. 4419-4431

AJOL African Journals Online